Uncategorized

FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions – CNBC

Posted on Author Comments Off on FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions – CNBC
  1. FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions  CNBC
  2. FDA reaffirms decision to erase Eli Lilly’s tirzepatide from shortage list, halting future flow of knockoffs  FiercePharma
  3. Does This News From the FDA Make Eli Lilly a Buy for 2025?  The Motley Fool
  4. FDA says knockoff versions of obesity drug must come off the market  East Idaho News
  5. FDA finalizes decision to end Lilly’s GLP-1 shortage, analysts predict Novo will be next  Yahoo Finance